Temocillin in the Treatment of Serious Gram-Negative Infections
- 1 January 1985
- journal article
- Published by Springer Nature in Drugs
- Vol. 29 (Supplement) , 191-193
- https://doi.org/10.2165/00003495-198500295-00041
Abstract
Temocillin was used to treat 32 patients with proven or suspected infection caused by aerobic Gram-negative bacteria. 25 of these patients were assessable on clinical and bacteriological grounds. All 25 were either cured or improved, although in 5 patients with urinary tract infection there was relapse of infection or reinfection following the cessation of therapy. Clinical improvement was usually rapid and no serious side effect was noted. Temocillin would thus appear to be an effective and safe agent for the treatment of bacterial infection caused by aerobic Gram-negative organisms.Keywords
This publication has 1 reference indexed in Scilit:
- BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humansAntimicrobial Agents and Chemotherapy, 1981